United Therapeutics
UTHR
$223.93
Share price
1.48%
Change (1 day)
-2.01%
Change (1 year)
Categories
United Therapeutics (UTHR) - Total liabilities
Total liabilities on the balance sheet as of June 2023 : $1.27 B
According to United Therapeutics's latest financial reports the company's total liabilities are $1.27 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
United Therapeutics - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $1.24 B | 3.11% |
| 2021-12-31 | $1.21 B | -0.79% |
| 2020-12-31 | $1.21 B | 7.66% |
| 2019-12-31 | $1.13 B | 85.01% |
| 2018-12-31 | $0.61 B | -21.24% |
| 2017-12-31 | $0.77 B | 67.8% |
| 2016-12-31 | $0.46 B | -20.76% |
| 2015-12-31 | $0.58 B | -5.5% |
| 2014-12-31 | $0.61 B | -20.99% |
| 2013-12-31 | $0.78 B | 47.3% |
| 2012-12-31 | $0.53 B | -6.65% |
| 2011-12-31 | $0.56 B | 3.99% |
| 2010-12-31 | $0.54 B | 37.44% |
| 2009-12-31 | $0.39 B | 9.6% |
| 2008-12-31 | $0.36 B | 24.86% |
| 2007-12-31 | $0.29 B | 6.31% |
| 2006-12-31 | $0.27 B | 1579.5% |
| 2005-12-31 | $16.31 M | 5.08% |
| 2004-12-31 | $15.52 M | 32.25% |
| 2003-12-31 | $11.73 M | -9.07% |
| 2002-12-31 | $12.9 M | -17.9% |
| 2001-12-31 | $15.72 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $94.38 B | 7,329.82% | 🇺🇸 USA |
 Eli Lilly LLY | $43.66 B | 3,337.35% | 🇺🇸 USA |
 Baxter BAX | $22.25 B | 1,651.87% | 🇺🇸 USA |
 Gilead Sciences GILD | $41.24 B | 3,146.71% | 🇺🇸 USA |
 Cardinal Health CAH | $46.26 B | 3,542.29% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $59.66 B | 4,597.29% | 🇬🇧 UK |
 Cytokinetics
CYTK | $1.11 B | -12.38% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $35.38 B | 2,685.72% | 🇮🇱 Israel |